A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
Condition: Healthy Interventions: Drug: Adalimumab; Drug: Lipopolysaccharide (LPS) Sponsor: Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2023 Category: Research Source Type: clinical trials